Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
IMRIS Inc. (IMRSQ)
CA
Based in Winnipeg, Canada, and established in 2005, IMRIS Inc. is a global leader in developing, producing, and distributing advanced image-guided therapy solutions. The company's flagship offering is the VISIUS Surgical Theatre, a sophisticated operating room environment. This unique system empowers medical professionals with real-time, intraoperative visual data, thereby aiding critical decision-making and significantly boosting the precision of patient treatments. The VISIUS Surgical Theatre integrates advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and fluoroscopy directly into multi-purpose surgical suites, bringing state-of-the-art diagnostic capabilities right into the operating room for diverse medical procedures. IMRIS primarily sells these integrated theatres to hospitals that provide clinical care in neurosurgical, spinal, cerebrovascular, and cardiovascular specialties. Complementing its core systems, the company also offers comprehensive service plans, extended maintenance agreements, and a variety of essential accessories and disposables.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -88.10% | +0.00% | +0.00% | +0.00% | +0.00% | +900.00% | +900.00% | +900.00% | +900.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Specialties: +8.3%-37.3% Q4'14: -4.3% (vs Q4'13)
-
EPS growth Medical - Specialties: +10.1%+30.1% ★ Q4'14: +69.0% (vs Q4'13)
-
FCF margin FCF growth · Medical - Specialties: +51.3%-59.5% Q4'14: -21.7% (vs Q4'13)
-
EBIT margin Medical - Specialties: +12.6%-88.5% Q4'14: -55.8% (vs Q4'13)
-
ROIC Medical - Specialties: +6.6%-84.5% Q4'14: -70.5% (vs Q4'13)
-
Share dilution Medical - Specialties: 0.0%+3.4% Q4'14: +2.8% (vs Q4'13)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×-1.03× Q4'14: -1.26× (vs Q4'13)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| A. Gregory Sorensen | Executive Chairman | — | — |
| Alan Weinberg | Vice President of Marketing & Product Management | — | male |
| Alex Vargas | Executive Board Member | — | male |
| Chris Myers | Vice President of Sales & Clinical | — | male |
| Joanne Branand | Vice President Finance & IT | — | female |
| Matthias Bergin | Executive Board Member | — | male |
| Shahin Pourrahimi | President of SSI | — | — |
| Shalabh Chandra | Chief Executive Officer & Director | — | male |
| Tracy Brinkmeyer | Senior Vice President of Operations & Human Resources | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IMRSQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
